Security key
87583X109
Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (TNGX)
CUSIP: 87583X109
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 143,181,938
- Total 13F shares
- 68,320,832
- Share change
- -1,516,270
- Total reported value
- $226,845,382
- Price per share
- $3.32
- Number of holders
- 89
- Value change
- -$7,737,842
- Number of buys
- 33
- Number of sells
- 44
Report period
Q2 2023
Institutions
89
Top holders
10
TNGX full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Tango Therapeutics, Inc. SEC filings
Tango Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87583X109
Recent filing periods:
Top shareholders of TNGX - Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TRV GP IV, LLC |
13F
|
Company |
14%
|
19,363,975
|
$76,487,701 | — | 31 Mar 2023 | |
| BCTG Holdings, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
6,988,450
|
$58,642,879 | — | 10 Aug 2021 | |
| FMR LLC |
13F
|
Company |
6.6%
|
9,508,929
|
$37,560,269 | — | 31 Mar 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
5%
|
7,123,642
|
$28,138,000 | — | 31 Mar 2023 | |
| Southpoint Capital Advisors LP |
13F
|
Company |
3.1%
|
4,500,000
|
$17,775,000 | — | 31 Mar 2023 | |
| EcoR1 Capital, LLC |
13F
|
Company |
2.9%
|
4,201,414
|
$16,595,585 | — | 31 Mar 2023 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2.9%
|
4,116,949
|
$16,262,000 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.5%
|
3,538,912
|
$13,978,703 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.9%
|
2,749,922
|
$10,862,193 | — | 31 Mar 2023 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
1.3%
|
1,921,790
|
$7,591,000 | — | 31 Mar 2023 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
1.1%
|
1,640,000
|
$6,478,000 | — | 31 Mar 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.83%
|
1,191,681
|
$4,707,140 | — | 31 Mar 2023 | |
| Casdin Capital, LLC |
13F
|
Company |
0.7%
|
1,000,000
|
$3,950,000 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.62%
|
886,871
|
$3,503,140 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.57%
|
821,529
|
$3,245,040 | — | 31 Mar 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.52%
|
750,000
|
$2,962,500 | — | 31 Mar 2023 | |
| HARVARD MANAGEMENT CO INC |
13F
|
Company |
0.49%
|
708,385
|
$2,798,121 | — | 31 Mar 2023 | |
| BESSEMER GROUP INC |
13F
|
Company |
0.49%
|
708,384
|
$2,798,000 | — | 31 Mar 2023 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.44%
|
630,000
|
$2,488,500 | — | 31 Mar 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.35%
|
495,213
|
$1,956,091 | — | 31 Mar 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.28%
|
405,565
|
$1,601,982 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.28%
|
398,494
|
$1,574,051 | — | 31 Mar 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.25%
|
361,194
|
$1,426,716 | — | 31 Mar 2023 | |
| Alan Huang |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
357,765
mixed-class rows
|
$1,406,264 | — | 01 Mar 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.14%
|
200,000
|
$790,000 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.14%
|
198,163
|
$783,000 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.12%
|
173,062
|
$683,595 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.11%
|
161,783
|
$639,000 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.1%
|
141,404
|
$558,546 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.09%
|
123,857
|
$489,235 | — | 31 Mar 2023 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
104,600
|
$413,170 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
99,767
|
$394,080 | — | 31 Mar 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.06%
|
92,738
|
$366,315 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
81,159
|
$320,578 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
75,591
|
$298,583 | — | 31 Mar 2023 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.05%
|
74,338
|
$293,635 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.05%
|
73,256
|
$289,361 | — | 31 Mar 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
71,721
|
$283,000 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.04%
|
60,969
|
$241,000 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.04%
|
60,900
|
$241,000 | — | 31 Mar 2023 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
59,865
|
$236,467 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
59,529
|
$235,140 | — | 31 Mar 2023 | |
| Braslyn Ltd. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
26,961
|
$226,241 | — | 10 Aug 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.04%
|
53,844
|
$212,683 | — | 31 Mar 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.04%
|
52,444
|
$207,154 | — | 31 Mar 2023 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.03%
|
43,736
|
$172,757 | — | 31 Mar 2023 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.03%
|
40,088
|
$158,000 | — | 31 Mar 2023 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
0.03%
|
40,000
|
$158,000 | — | 31 Mar 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
33,958
|
$134,134 | — | 31 Mar 2023 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.02%
|
32,997
|
$130,338 | — | 31 Mar 2023 |
Institutional Holders of Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (TNGX) as of Q2 2023
As of 30 Jun 2023,
Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (TNGX) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,320,832 shares.
The largest 10 holders included
TRV GP IV, LLC, FMR LLC, Boxer Capital, LLC, Southpoint Capital Advisors LP, EcoR1 Capital, LLC, BlackRock Inc., VANGUARD GROUP INC, Bain Capital Life Sciences Investors, LLC, Soleus Capital Management, L.P., and Avoro Capital Advisors LLC.
This page lists
89
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
91
Q2 2023 holders
89
Holder diff
-2
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.